Intensive and Perioperative Care, Skane University Hospital
Lund, 22185, Sweden
Location status: Recruiting
Location contact
Johan Smålander, CRNA
SUB_INVESTIGATOR
Malin Rundgren, MD, PhD
CONTACT
NCT Number: NCT06922487
Occasional patients with intracranial tumors need to have a planned awakening during surgery to avoid major disability from the tumor resection. During the awake part of the surgery an increasing degree of tiredness is observed. For the surgeon to plan the resection knowledge of the degree and speed of tiredness/sleepiness evolution is important.
The goal of this single center study is to use the "Karolinska Sleepiness Scale" during and after awake surgery for neurosurgical tumor resection to quantify the time available for surgical intervention.
Participants are adults having planned surgery for open resection of intracranial tumor with a planned awakening for assessment during surgery. Participants will be asked to grade postoperative sleepiness using the "Karolinska Sleepiness Scale".
Interested in participating?
Request Info18 year and older
All sexes
Observational
Lund, 22185, Sweden
Location status: Recruiting
Johan Smålander, CRNA
SUB_INVESTIGATOR
Malin Rundgren, MD, PhD
CONTACT
Background The incidence of primary tumors in the central nervous system in adults in Sweden is approximately 1400 per year. Gliomas constitutes the most common form, approximately 50%. The neurosurgery aims at securing material for pathological-anatomical diagnosis, reduction of symptoms, maximal reduction of tumor mass with minimal functional impact. Occasional patients present with tumors in sensitive areas necessitating operation with the patient awake and co-operable to optimize the resection. The procedure is typically performed as an asleep-awake-asleep procedure. A clinical observation is that the patients tend to become increasingly sleepy/tired during resection. This study aims to quantify this phenomenon.
Methods Ethical review board approval (Dnr 2024-01935-01, Stockholm, Sweden) is present.
The study is a single center kohort study.
Participants will be identified by the neurosurgeon planning tumor resection with intraoperative awake surgery. Inclusion and information are given preoperatively by the neurosurgeon and the anesthetist.
All participants receive propofol/remifentanil based general anesthesia with norepinephrine infusion to support blood-pressure during preparation and craniotomy whereafter the participant is awakened. The resection starts when the participant is coherent and cooperative. Peroperative level of sedation is assessed using Karolinska Sleepiness Scale (KSS) every 15 minutes. KSS is an ordinal nine grade scale assessing sleepiness during the last five minutes from "extremely alert" to "very sleepy, great effort to keep awake, fighting sleep". When the resection is completed the participants receives general anesthesia during wound closure. Postoperative level of sedation is assessed using Karolinska Sleepiness Scale (KSS) during the first two postoperative hours.
Data regarding age, sex, length, weight, comorbidities, tumor location, ASA- classification and preoperative medication will be collected. Peroperative vital parameters and pEEG -results and data from infusion pumps are primarily collected electronically. The manually kept anesthetic notes are copied and stored as back-up. All individual data are de-identified and coded after collection.
Inclusion and exclusion criteria Inclusion Adult (>18 years old) Elective supra or infratentorial tumor resection via craniotomy Surgical need for awake surgery Cognitive function allowing informed consent.
Exclusion Tumor localization not allowing placement of BIS electrodes due to interference with surgery Morbid obesitas
Outcomes Peroperative degree of sleepiness measured with Karolinska Sleepiness Scale (KSS).
Statistical methods and power calculation The study is a descriptive cohort study. A convenience sample of participants fulfilling inclusion criteria during the inclusion time will be used. The primary goal is to include at least 10 participants. As primary KSS variable a deviation of two or more units will be considered a significant change. Time from start of resection until significant change in KSS is the primary endpoint.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assessment of sleepiness during resection using KSS
Time frame: during surgery and 2 hours postoperatively
Change in KSS during resection
Contact information is provided by the study sponsor or research team.
Region Skane
Other
Förekomsten av trötthet Vid Neurokirurgisk Vakenkirurgi
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06962215
Brain Diseases, Brain Neoplasms
Brest, Brittany Region, France
View Trial DetailsNCT03213002
Astrocytoma, Brain Cancer
New York, United States
View Trial DetailsNCT07411690
Astrocytoma, Brain Diseases
Warsaw, Poland
View Trial DetailsNCT07413796
Astrocytoma, Brain Diseases
Warsaw, Masovian Voivodeship, Poland
View Trial Details